Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy
Study Details
Study Description
Brief Summary
The purpose of the study was to investigate the impact of aerobic exercise combined with diet protocol on the immune system in post-mastectomy patients receiving chemotherapy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Chemotherapy reduces circulating lymphocytes levels, which affect lymphocytes in breast cancer patients during the therapy itself or up to 3 months after the last chemotherapy cycle, so the study is developed to investigate the impact of aerobic exercise combined with diet protocol on the immune system in post-mastectomy patients receiving chemotherapy. Sixty post-mastectomy women were receiving chemotherapy and aged from 40-60 years selected from the outpatient clinic of the oncology department in the New Cairo hospital in the Police Academy. They will be assigned randomly into three equal groups, the aerobic exercises and diet protocol group, the diet protocol group, and the aerobic exercises group. The immunological markers; total lymphocyte count (TLC), neutrophil-to-lymphocyte ratio(NLR), and platelet-to-lymphocyte ratio(PLR) will be measured at baseline and after twelve weeks of intervention.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Aerobic exercises and diet protocol group The participant will be managed by aerobic exercise by using a treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes after the second week in addition to the diet protocol specific diet designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins for twelve weeks. |
Other: Aerobic exercises
Aerobic exercise by using the treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes in weeks 2-12.
Other: Diet protocol
A specific diet for three months is designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins.
|
Active Comparator: Diet protocol group The participant will be managed by a specific diet protocol designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins for twelve weeks. |
Other: Diet protocol
A specific diet for three months is designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins.
|
Active Comparator: Aerobic exercises group The participant will be managed by aerobic exercise by using a treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes after the second week for twelve weeks as a total treatment time. |
Other: Aerobic exercises
Aerobic exercise by using the treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes in weeks 2-12.
|
Outcome Measures
Primary Outcome Measures
- The change in total lymphocyte count. [Baseline and twelve weeks after the intervention.]
from patient's blood sample analysis for immunological markers in lab.
- The change in neutrophil to lymphocyte ratio. [Baseline and twelve weeks after the intervention.]
from patient's blood sample analysis for immunological markers in lab.
- The change in platelet to lymphocyte ratio. [Baseline and twelve weeks after the intervention.]
from patient's blood sample analysis for immunological markers in lab.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Female post-mastectomy patients.
-
Age range is between 40-60 years old.
-
All patients will enter the study after having their informed consent.
-
All patients are undergoing chemotherapy treatment with AC protocol (Adriamycin with endoxan) for four cycles (every 21 days ).
-
All patients have finished the first stage of chemotherapy treatment
Exclusion Criteria:
-
Cardiac disease patients.
-
Uncontrolled hypertension patients.
-
Patients with thyroid disease.
-
Patients with lymphatic complications.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shaimaa Mohamed Ahmed Elsayeh | Cairo | New Cairo | Egypt | 02 |
Sponsors and Collaborators
- Cairo University
Investigators
- Study Director: Shaimaa MA Elsayeh, PhD, Cairo University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- P.T.REC/012/003747